25h Hotel Zürich Langstrasse
The development of innovative therapeutic avenues in oncology is a complex multi-disciplinary process. The clinical and basic aspects of tumor biology have to be integrated in an early phase to enable the best possible outcome.
The creation of a translational network, including basic/translational and clinical researcher may create awareness of clinical needs among the implementation process of new ideas developed in the laboratory. Conversely, clinical researchers may learn about opportunities to develop new ideas beyond standard daily practice.
Importantly, young investigators both in clinical and in translational research, are the key audience for this meeting. A collaboration between institutions and researchers will be facilitated and supported.
participation including hotel: CHF 250.-
participation without hotel: CHF 160.-
Presentations of ongoing research projects is highly encouraged. The aim is to give a short presentation (15 min) followed by 15 min discussion and input from the audience and experts that are present. Please send your abstract to email@example.com. Submission deadline is August 31, 2022. Please contact Jean-Philippe Theurillat or Aurelius Omlin in case of any questions relating to the presentations. For presenters of projects participation at the event is free of charge (hotel and registration).
Registration: The registration form is closed. For late registration please contact us via firstname.lastname@example.org
Award details can be found below under "Award Rules and Registrations". Please submit your application by August 31, 2022 latest to email@example.com.
SAKK Coordinating Center
Tel: +41 31 389 91 91
Prof. Dr. med. Jean-Philippe Theurillat
Institute of Oncology Research (IOR)
Via Vincenzo Vela 6
+41 91 821 0075